Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy USANA Health Sciences stock

Own USANA Health Sciences stock in just a few minutes.

USANA Health Sciences, Inc is a household & personal products business based in the US. USANA Health Sciences shares (USNA) are listed on the NYSE and all prices are listed in US Dollars. USANA Health Sciences employs 1,943 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in USANA Health Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – USNA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

USANA Health Sciences share price

Use our graph to track the performance of USNA stocks over time.

USANA Health Sciences shares at a glance

Information last updated 2021-04-23.
52-week range$68.30 - $102.96
50-day moving average $99.10
200-day moving average $85.79
Wall St. target price$112.50
PE ratio 16.6075
Dividend yield N/A (0%)
Earnings per share (TTM) $5.86

Buy USANA Health Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs, Currencies
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy USANA Health Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Is USANA Health Sciences under- or over-valued?

Valuing USANA Health Sciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of USANA Health Sciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

USANA Health Sciences's P/E ratio

USANA Health Sciences's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 17x. In other words, USANA Health Sciences shares trade at around 17x recent earnings.

That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.

USANA Health Sciences's PEG ratio

USANA Health Sciences's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0695. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into USANA Health Sciences's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

USANA Health Sciences's EBITDA

USANA Health Sciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $190.2 million.

The EBITDA is a measure of a USANA Health Sciences's overall financial performance and is widely used to measure a its profitability.

USANA Health Sciences financials

Revenue TTM $1.1 billion
Operating margin TTM 15.56%
Gross profit TTM $925.5 million
Return on assets TTM 19.05%
Return on equity TTM 31.43%
Profit margin 10.99%
Book value $20.99
Market capitalisation $2.1 billion

TTM: trailing 12 months

Shorting USANA Health Sciences shares

There are currently 699,526 USANA Health Sciences shares held short by investors – that's known as USANA Health Sciences's "short interest". This figure is 1.7% up from 687,524 last month.

There are a few different ways that this level of interest in shorting USANA Health Sciences shares can be evaluated.

USANA Health Sciences's "short interest ratio" (SIR)

USANA Health Sciences's "short interest ratio" (SIR) is the quantity of USANA Health Sciences shares currently shorted divided by the average quantity of USANA Health Sciences shares traded daily (recently around 144530.16528926). USANA Health Sciences's SIR currently stands at 4.84. In other words for every 100,000 USANA Health Sciences shares traded daily on the market, roughly 4840 shares are currently held short.

However USANA Health Sciences's short interest can also be evaluated against the total number of USANA Health Sciences shares, or, against the total number of tradable USANA Health Sciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case USANA Health Sciences's short interest could be expressed as 0.03% of the outstanding shares (for every 100,000 USANA Health Sciences shares in existence, roughly 30 shares are currently held short) or 0.0554% of the tradable shares (for every 100,000 tradable USANA Health Sciences shares, roughly 55 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against USANA Health Sciences.

Find out more about how you can short USANA Health Sciences stock.

USANA Health Sciences share dividends

We're not expecting USANA Health Sciences to pay a dividend over the next 12 months.

Have USANA Health Sciences's shares ever split?

USANA Health Sciences's shares were split on a 2:1 basis on 22 November 2016. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your USANA Health Sciences shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for USANA Health Sciences shares which in turn could have impacted USANA Health Sciences's share price.

USANA Health Sciences share price volatility

Over the last 12 months, USANA Health Sciences's shares have ranged in value from as little as $68.3 up to $102.96. A popular way to gauge a stock's volatility is its "beta".

USNA.US volatility(beta: 0.98)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while USANA Health Sciences's is 0.9818. This would suggest that USANA Health Sciences's shares are less volatile than average (for this exchange).

USANA Health Sciences overview

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. USANA Health Sciences, Inc.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site